Loading...
Long-term results of a phase II study of hypofractionated proton therapy for prostate cancer: moderate versus extreme hypofractionation
BACKGROUND: We performed a prospective phase II study to compare acute toxicity among five different hypofractionated schedules using proton therapy. This study was an exploratory analysis to investigate the secondary end-point of biochemical failure-free survival (BCFFS) of patients with long-term...
Saved in:
| Published in: | Radiat Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6327508/ https://ncbi.nlm.nih.gov/pubmed/30630500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-019-1210-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|